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The influence ofiron chelators on the accumulation ofprotoporphyrin IX in
5-aminolaevulinic acid-treated cells
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Summary Human adenocarcinoma cells of the line WiDr and Chinese hamster lung fibroblasts ofthe line V79
were treated with 5-aminolaevulinic acid (5-ALA) and exposed to light. The effects of the iron chelators
ethylenediaminetetraacetic acid (EDTA) and desferrioxamine (DEF) were assessed. Both cell lines were treated
with various concentrations of 5-ALA in the presence or absence of the iron chelators for 4 h in serum-free
medium. The accumulation of protoporphyrin IX (PpIX) reached a maximum level at 1 mm 5-ALA in WiDr
cells [280 ng PpIX (mg protein x 4 h-1] and at 0.1 mM 5-ALA in V79 cells [55 ng PpIX (mg protein x 4 h) 1].
PpIX was the only fluorescing porphyrin in these cells after 5-ALA treatment alone or in combination with the
chelators. The iron chelators did not influence the intracellular localisation pattern of PpIX in 5-ALA-treated
cells. While both chelators enhanced the accumulation of PpIX in 5-ALA-treated cells, DEF was found to be
superior at equal concentrations. A linear relationship between the applied concentration of DEF and the
DEF-induced increase in PpIX accumulation was observed in double-reciprocal plots. The intercepts of the
regression lines with the ordinate indicate that the ferrochelatase is saturated with PpIX when the 5-ALA
concentration exceeds 0.3 mm and 0.05 mm in WiDr and V79 cells respectively. The DEF-induced
enhancement of PpIX accumulation in 5-ALA-treated cells was cell line and 5-ALA concentration dependent.
At a 5-ALA concentration inducing a maximum level of PpIX accumulation, inhibition of ferrochelatase
activity enhanced the PpIX accumulation 3- and 1.4-fold in V79 and WiDr cells respectively. The relative gain
in PpIX accumulation increased with decreasing concentration of 5-ALA. In cells treated with the lowest
concentrations of 5-ALA used in this study, DEF enhanced PpIX accumulation 44- and 3.5-fold in V79 and
WiDr cells respectively. The iron chelator-induced increase in cellular PpIX accumulation was followed by a
similar increase in sensitivity to photoinactivation. The ferrochelatase inhibitor dihydropyridine 3,5-
diethoxycarbonyl-1,4-dihydrocollidine reduced the accumulation of PpIX in both cell lines.
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Worldwide, photochemotherapy (PCT) is being evaluated as
a new modality of cancer treatment (Henderson and
Dougherty, 1992; Moan and Berg, 1992). It is based on
injection of photosensitising and tumour localising dyes
followed by exposure of the tumour region to high fluences
of light, usually from a laser. A variety of different types of
tumours respond to PCT.
The fact that certain porphyrins administered to tumour-
bearing animals tend to accumulate in tumour tissue has been
known for more than 50 years (Policard, 1924). Since most
porphyrins exhibit a characteristic red fluorescence, their
tumour-localising properties can be used for tumour
detection (Lipson et al., 1967; Pope et al., 1991). The
photosensitising properties of porphyrins, together with their
tumour-localising properties, were first exploited for ther-
apeutic purposes by Auler and Banzer (1943). The first cancer
patients were treated with porphyrin-based PCT in 1976
(Kelly and Snell, 1976), and today more than 10 000 patients
have been treated with PCT.
A somewhat different approach to PCT is based on the
endogenous synthesis of porphyrins (Malik and Lugaci, 1987;
Kennedy and Pottier, 1992). The initial step in the porphyrin
synthesis pathway is the 5-aminolaevulinic acid (ALA)
synthase-induced formation of 5-aminolaevulinic acid from
succinyl-CoA and glycine. This pathway, ultimately leading
to the formation of haem, is regulated by the feedback
inhibition of ALA synthase activity by haem (Kennedy et al.,
1990). The feedback regulation is overruled by treating cells
with 5-ALA. Several porphyrinogens are formed by the
pathway, from which photoactive porphyrins can be formed
by auto-oxidation. Fortunately for the treatment of cancer,
the ferrochelatase (protohaem ferrolyase, EC 4.99.1.1)
activity needed for the incorporation of iron into the
protoporphyrin IX macrocycle, is low in neoplastic cells
(Dailey and Smith, 1984; van Hillegersberg et al., 1992;
Schoenfeld et al., 1988; el-Sharabasy et al., 1992). Oseroffand
coworkers hypothesise that malignant cells that have an
increased expression of transferrin receptors will also have
low levels of intracellular iron (Rittenhouse-Diakun et al.,
1995). Furthermore, fast-growing neoplastic cells usually have
an elevated capability for synthesising porphyrins compared
with their normal counterparts. Thus, ALA has been used
with great success for the treatment of several neoplastic
diseases. A large clinical experience already exists on the
treatment of basal and squamous cell carcinoma of the skin.
The results obtained show very good clinical responses and
cosmetic outcome of the treatment (Heyerdahl et al., 1993).
However, the PCT effects on lesions thicker than > 1 mm
need to be improved.
A crucial point for the success of ALA-PCT is a low
ferrochelatase activity in the tumour. However, all porphyrin-
producing cells contain some ferrochelatase activity. Inhibi-
tion of the ferrochelatase activity by chelators of iron has
been found to enhance the accumulation of PpIX as well as
the sensitivity of cells to ALA-induced photosensitisation
(Hanania and Malik, 1992; Ortel et al., 1993). The two most
commonly used chelators for this purpose are ethylenedia-
minetetraacetic acid (EDTA), an unspecific membrane-
impermeable chelator, and desferrioxamine (DEF), which is
specific for iron and can penetrate into the cellular cytosol.
The ratio between the ALA-induced formation of PpIX and
the cellular capability of incorporating iron into the PpIX
macrocycle may be dependent on the cell line and on the
ALA concentration. So far, no studies have been performed
to compare the efficacy of these chelators in enhancing the
PpIX accumulation in the same cell lines. In the present study
EDTA and DEF were compared for their effects in enhancing
ALA-induced PpIX accumulation and photosensitisation in
two cell lines of different origin and with different growth
rates. The maximal effect of DEF on PpIX accumulation in
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5-ALA-treated cells was also estimated. Additionally, 3,5-
diethoxycarbonyl-1,4-dihydrocollidine (DDC), a methylated
dihydropyridine, which N-alkylates porphyrins and thereby
inhibits the ferrochelatase, was also investigated for its
potentially modulating effect on PpIX accumulation.
Materials and methods
Cell cultivation
Cells of the established line WiDr (doubling time ,30 h),
derived from a primary adenocarcinoma of the rectosigmoid
colon (Noguchi et al., 1979), and V79 cells (doubling time %
10 h), derived from Chinese hamster lung fibroblasts, were
used. Both cell lines were grown in RPMI-1640 medium
containing 10% fetal calf serum (FCS), 100 U ml-' penicillin
and 100 ig ml-' streptomycin at 37°C in an incubator
flushed with 5% carbon dioxide in air. The cells were
subcultured twice a week (split ratio 1:100).
Chemicals
5-ALA, provided by Porphyrin Products (Logan, UT, USA),
was dissolved in Dulbecco's phosphate-buffered saline (PBS)
and the pH adjusted to 7.0 by means of 5 M sodium
hydroxide. The stock solution was made the same day as it
was used. DEF, EDTA and DDC were purchased from
Aldrich (Milwaukee, WI, USA).
Labelling with 5-ALA and irradiation
The cells were inoculated in 25 cm2 plastic tissue-culture
flasks (Nunclon) and left overnight for proper attachment to
the substratum. The next day the cells were treated with PCT.
Cells treated with PCT were washed with RPMI-1640
without serum and incubated for 4 h in RPMI-1640 without
serum, containing 5-ALA. The cells were exposed to light
from a bank of four fluorescent tubes (model 3026, Applied
Photophysics, London, UK) emitting light mainly around
405 nm (Berg et al., 1988). The fluence rate of the light
reaching the cells was 36 W m-2. The medium was removed
immediately after illumination and replaced with 5-ALA-free
RPMI-1640 containing 10% FCS.
Cell survival
Cell survival was measured by the colony-forming test as
previously described (Berg et al., 1991). Approximately 500
cells were inoculated in 25 cm2 plastic tissue culture flasks
and treated with 5-ALA and light as described above. After
photochemical treatment the V79 and WiDr cells were left for
5 and 10 days, respectively, at 37°C in serum-containing
culture medium to allow for formation of countable colonies.
The cells were then fixed in ethanol, stained with methylene
blue and the colonies counted. The treatment of the cells with
5-ALA, as performed in the present study, did not reduce the
colony-forming ability of the cells.
Measurements of cellular PpIX contents
Approximately 5 x 105 WiDr and 4 x 105 V79 cells were
seeded into 10 cm2 dishes (Nunclon) and treated with 5-ALA
as described above. The cells were then washed once in PBS
and brought into a solution containing 1 M perchloric acid in
50% methanol by scraping with a Costar cell scraper. After
5 min of incubation the cell debris was removed by
centrifugation. PpIX was quantitatively extracted from the
cells with this procedure. The PpIX content of the samples
was detected spectrofluorometrically using a Perkin Elmer
LSSOB spectrofluorometer. The PpIX was excited at 408 nm
and the fluorescence was measured at 605 nm. A long pass
cut-off filter (530 nm) was used on the emission side. A
standard of known concentration was added to the samples
at a concentration increasing the total fluorescence by 50-
100%. The protein content was measured by the Lowry
method (Lowry et al., 1951).
High-performance liquid chromatography (HPLC)
The porphyrins were extracted from the cells by scraping the
cells in acidified methanol (5 ,l concentrated hydrochloric
acid in 10 ml of methanol). The cell debris was pelleted and
the supernatant collected. The porphyrins were concentrated
by flushing the extracts with nitrogen until the volume was
reduced to approximately 150-200 Ml and additionally
precipitated proteins were pelleted. The supernatant (100 pl)
was mixed with 235 yl of 10 mM sodium phosphate, pH
adjusted to approximately 10.5 by means of 5 M potassium
hydroxide and directly used for HPLC analysis. The
porphyrins were quantitatively extracted from the cells by
this procedure.
The HPLC system consisted of a pump (Spectra Physics
8800), a reversed phase column [Supelcosil LC-18-T
(4.6 x 250 mm), Supelco, Gland, Switzerland], an absorption
detector (Spectra Physics Spectra 200) and an integrator
(Spectra Physics Data-jet) connected to a computer. The start
solvent was a mixture of methanol and water (70:30 by
volume) containing 1.5 mM phosphate, adjusted to pH 7.0.
The end solvent was a mixture of methanol and water (95: 5
by volume) containing 1.5 mM phosphate, adjusted to pH
7.5. A 30 min linear gradient between 70% and 82% of
methanol was applied followed by a 5 min linear gradient to
95% of methanol and 5 min at 95% of methanol. The
absorption was detected at 405 nm.
Fluorescence microscopy
Twenty-eight cm2 dishes (Falcon 3002) were used in the
microscopical studies. The cells were washed once with PBS
and a cover glass was gently put on top of a PBS layer. The
cells were subsequently studied by a Zeiss Axioplan
microscope equipped with epifluorescence. A HBO/100 W
mercury lamp was used for excitation. The cells and the
cellular fluorescence were studied by means of a cooled
charge-coupled device (CCD) camera (TE2, Astromed,
Cambridge). A computer controlled the camera operation
and was used for digital image processing and storage. The
microscope was equipped with a 390-440 nm band pass
excitation filter, a 470 nm dichroic beam splitter and a
600 nm long-pass filter.
Results
Porphyrin synthesis in V79 and WiDr cells
Porphyrin synthesis was stimulated by 5-ALA treatment both
in the fast-growing V79 cells and in the more slowly growing
WiDr cells (Figure 1). In both cell lines the same sigmoidal-
shaped curves for the 5-ALA-dependent PpIX formation
were found. The rate of PpIX synthesis reached in both cases
a maximum, 280 ng PpIX (mg protein)-' for the WiDr cells
and 55 ng PpIX (mg protein)-' for the V79 cells after 4 h of
5-ALA treatment. The maximum PpIX formation was
achieved by treating the V79 cells with 0.1 mM 5-ALA,
whereas 1.0 mM was necessary for reaching the maximum in
WiDr cells. The colony-forming ability of both cell lines was
inhibited by 4 h treatment with 5-ALA concentrations higher
than 1.5 mM (data not shown).
Effect of iron chelators and DDC on PpIX accumulation
Three different concentrations of 5-ALA were selected for
studying the effect of iron chelators on PpIX accumulation,
i.e. concentrations of 5-ALA inducing nearly no PpIX
(0.025 mm and 0.1 mM 5-ALA for V79 and WiDr cells
respectively), approximately 50% of maximum capacity for
PpIX synthesis (0.05 mM and 0.3 mM 5-ALA for V79 and
WiDr cells respectively), and maximum capacity for PpIXALA-PDT and iron chelators
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synthesis (0.1 mm and 1 mM 5-ALA for V79 and WiDr cells
respectively). In WiDr cells, EDTA treatments up to 100 ,UM
induced only an insignificant increase in the biosynthesis of
PpIX (Figure 2a). In Figure 3a the same results are plotted as
the increase in PpIX accumulation relative to the accumula-
tion in cells treated with 5-ALA only. As seen from the figure
the relative effect of EDTA was most pronounced at the
lowest concentrations of 5-ALA. A more substantial increase
in PpIX accumulation was observed after cotreatment with
DEF (Figure 2b). Similar to the effect of EDTA treatment,
the most pronounced DEF-induced enhancement of PpIX
accumulation was observed at the lowest concentration of 5-
ALA applied (Figure 3b). At 0.1 mM 5-ALA, DEF (1000 ,UM)
increased the PpIX accumulation more than 3-fold. At the
same chelator concentration (100 guM), DEF still induced a
more pronounced accumulation of PpIX than EDTA (Figure
3). In contrast to the iron chelators, the dihydropyridine
DDC inhibited PpIX accumulation (Figure 2c), with the
highest inhibition occurring at the lowest 5-ALA concentra-
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tion applied (Figure 3c).
In V79 cells both EDTA and DEF significantly increased
the accumulation of PpIX at all selected concentrations of 5-
ALA (Figure 4). In particular, treatment with 1 mM DEF
was highly efficient, and the accumulation of PpIX was
enhanced 2.4-fold even at 0.1 mM 5-ALA. As in the case of
WiDr cells, the relative chelator-induced increase in PpIX
accumulation was inversely related to the applied concentra-
tion of 5-ALA (Figure 5). In V79 cells treated with 0.025 mM
5-ALA a more than 30-fold increase in PpIX accumulation
was often observed by cotreatment with 1 mM DEF. To
reveal the optimal 5-ALA concentration for DEF-induced
enhancement of PpIX accumulation, the 5-ALA concentra-
tion was varied in the range 0-0.05 mM in the absence or
presence of 1 mM DEF (Figure 6). DEF increased the PpIX
accumulation in the whole range studied with a maximum
enhancement at 0.020 mM 5-ALA. At the lowest concentra-
tions of 5-ALA applied, the absolute relative increase varied
between separate experiments as a result of a very low and
2.0 3.0
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Figure 1 PpIX formation in 5-ALA-treated V79 cells (0) and WiDr (0) cells. The cells were treated for 4h in serum-free medium
as described in Materials and methods. A close-up of the effect of treatment with less than 0.2mM 5-ALA is shown in b. The curve
for accumulation of PpIX in V79 cells is fitted to the following function: y=69.4 than (7848x2- 135x+ 0.09). Bars (s.d.) are shown
when larger than symbols.
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Figure 2 PpIX formation in WiDr cells treated with 5-ALA in combination with EDTA (a), DEF (b) or DDC (c). The cells were
treated for 4h in serum-free medium as described in Materials and methods with 5-ALA and 0 (0), 3 (A), 10 (0), 30 (O1), 100 (U)
or 1000 (V),M EDTA, DEF or DDC. Bars (s.d.) are shown when larger than symbols.ALA-PDT and iron chelators
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Figure 3 Relative increase in PpIX formation in WiDr cells treated with 5-ALA in combination with EDTA (a), DEF (b) or DDC
(c). The PpIX formation is presented as relative to the amount of PpIX in cells treated with 5-ALA only. V, 0.1 mm 5-ALA; 0,
0.3 mm 5-ALA; 0, mM 5-ALA. Bars (s.d.) are shown when larger than symbols.
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Figure 4 PpIX formation in V79 cells treated with 5-ALA alone
(0) or in combination with 100 1M (0) or mM (E]) EDTA,
l00 uM (0) or mm (V) DEF, or 100 uM (A) DDC. The cells
were treated for 4h in serum-free medium as described in
Materials and methods. Bars (s.d.) are shown when larger than
symbols.
variable formation of PpIX in cells treated in the absence of
DEF. As in the case of WiDr cells, DDC substantially
inhibited the accumulation of PpIX in the presence of 5-ALA
(Figure 4). CaMgEDTA concentrations up to 1 mM induced
an increase in PpIX accumulation which was lower than that
of EDTA (data not shown).
The increased accumulation of PpIX caused by DEF in 5-
ALA-treated cells can be visualised by subtraction of PpIX
formed in the presence of 5-ALA only (Figure 7). In both cell
lines the DEF-induced increase in PpIX accumulation seems
to be saturable. When these results are presented in a double-
reciprocal plot, the data fit well to linear regression curves
(Figure 8). The dotted lines in Figure 7 are based on the
linear regression curves obtained from Figure 8. The
intercepts of the regression curves in Figure 8 with the
ordinate axis is [AVmax] ', i.e. the maximum effect of DEF on
accumulation of PpIX at the selected concentration of 5-
ALA. In both cell lines the same AVmax was obtained with the
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Figure 5 Relative increase in PpIX formation in V79 cells
treated with 5-ALA in combination with I00gM (0) or mM (C])
EDTA, O00gUM (0) or I mM (V) DEF, or 100 gM (A) DDC. The
PpIX formation is presented as relative to the amount of PpIX in
cells treated with 5-ALA only. Bars (s.d.) are shown when larger
than symbols.
two highest concentrations of exogenously applied 5-ALA.
These data indicate that these 5-ALA concentrations saturate
the ferrochelatase with its substrate PpIX, and Vmax from
these 5-ALA concentrations therefore reflect the maximal
rate of iron insertion into PpIX in these cell lines under the
present conditions. The AVmax after treatment with the lowest
concentration of 5-ALA was substantially lower in both cell
lines, indicating that at these concentrations 5-ALA induced
formation of suboptimal concentrations of PpIX as a
substrate for ferrochelatase. The 5-ALA-induced formation
of PpIX and the maximum obtainable enhancement inducible
by DEF is illustrated in Figure 9. As pointed out above, at
the highest 5-ALA concentration the V79 cells and the WiDr
cells form 50 and 280 ng PpIX (mg protein)-1 after 4 h of
incubation respectively. The maximum DEF-inducible en-
hancement of PpIX accumulation is almost similar in V79
and WiDr cells, i.e. 93 and 124 ng PpIX (mg protein x 4 h)-'
respectively (Figure 9a). Thus, the maximal accumulation of
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Figure 6 Absolute (0O) and relative (El) formation of PpIX in
V79 cells treated with 5-ALA in the absence (0) or presence (0)
of 1 mM DEF. The cells were treated for 4h in serum-free medium
as described in Materials and methods.
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Figure 7 DEF-induced increase in PpIX accumulation in 5-
ALA-treated WiDr (a) and V79 (b) cells. The cells were treated
for 4h in serum-free medium in the presence of 0.1 mM (WiDr) or
0.025mM (V79) (El), 0.3 mM (WiDr) or 0.05 mM (V79) (0), 1 mM
(WiDr) or 0.1 mM (V79) (0) 5-ALA and DEF as indicated. The
increase in PpIX accumulation is deduced by subtraction of PpIX
in 5-ALA-treated cells from PpIX in cells treated with the same
concentration of 5-ALA and DEF.
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Figure 8 Double-reciprocal plots of the DEF-induced increase in
PpIX accumulation in 5-ALA-treated WiDr (a) and V79 (b) cells.
The cells were treated for 4h in serum-free medium in the
presence of 0.1 mM (WiDr) or 0.025mM (V79) (Ol), 0.3mM
(WiDr) or 0.05mM (V79) (0), ImM (WiDr) or 0.1mM (V79)
(0) 5-ALA and DEF as indicated. The increase in PpIX
accumulation is deduced by subtraction of PpIX in 5-ALA-
treated cells from PpIX in cells treated with the same
concentration of 5-ALA and DEF.
PpIX in the absence of iron available for the ferrochelatase is
140 and 404 ng PpIX (mg protein x4 h)'- for V79 and
WiDr cells respectively. At these concentrations of 5-ALA,
DEF can maximally increase the accumulation of PpIX 3-
and 1.4-fold in V79 and WiDr cells respectively. In a similar
way it can be estimated that for cells treated with the lowest
concentrations of 5-ALA used in this study, DEF may
enhance PpIX accumulation 44- and 3.5-fold in V79 and
WiDr cells respectively (Figure 9).
Analysis ofaccumulated porphyrin intermediates
The fluorescence emission spectrum of PpIX is slightly red-
shifted compared with the two other main intermediates in
the porphyrin synthesis pathway, uro- and coproporphyrin
(Granick et al., 1975). In our analysis of cellular contents of
porphyrins, the fluorescence emission spectra were similar to
that of PpIX, indicating that mainly PpIX was formed after
all types of treatments performed. This was confirmed by
HPLC analysis of extracts from cells treated with 5-ALA in
the presence or absence of modulators of the haem synthesis
pathway (Figure 10). No intermediate other than PpIX was
observed. These analyses clearly show that neither the iron
chelators, DEF or EDTA, nor DDC in combination with 5-
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Figure 9 Summary ofthe optimal DEF-inducible effect on PpIX
accumulation in WiDr and V79 cells cotreated with 5-ALA as
indicated in the figure. =, PpIX in cells treated with 5-ALA
only; M, maximal DEF-induced increase in PpIX accumulation
in 5-ALA-treated cells (deduced from intercepts with the
ordinates in Figure 8); _, total accumulation of PpIX in cells
treated with 5-ALA under conditions where ferrochelatase activity
is maximally inhibited by DEF, i.e. the sum of and M. The
maximal DEF-induced increase in PpIX accumulation is deduced
from Figure 8.
ALA treatment induce accumulation of other porphyrin
intermediates than does 5-ALA alone.
Intracellular localisation of PpIX
The intracellular localisation of PpIX in cells treated with 5-
ALA in the presence or absence of iron chelators was
assessed by fluorescence microscopy (Figure 11). PpIX seems
from these studies to localise in two or more compartments.
A large fraction of PpIX is diffusely located all over the cells
including the outer lining of the cells. This indicates that a
fraction of PpIX is associated with the plasma membrane.
The strong fluorescence at the border between the cells may
support this conclusion, but may also be due to PpIX located
in the extracellular space between interdigitating membranes
of the cells. Additionally, the low fluorescence intensity from
the nuclear area indicate cytoplasmic, most likely membrane-
associated, localisation of PpIX. As seen in Figure 11 this
cytoplasmically located PpIX is to a large extent focused in a
perinuclear spot. No difference in the distribution of PpIX
was observed between cells treated with 5-ALA alone or in
combination with iron chelators (Figure 11).
5-ALA-PCT in combination with iron chelators and DDC
EDTA, DEF and DDC in the absence or presence of 5-ALA
did not induce any cytotoxic effects during the experiments as
revealed by the trypan blue exclusion method. However, to
reveal any long-term effects of the drugs, a clonogenicity test
01-mm 5-ALA
+ mm DEF
+_gOjM DDC
+1 mm CaMgEDTA
+1 mM EDTA
URO COPRO PpIX
Standards
I I I L
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Figure 10 HPLC analysis of porphyrin extracts from V79 cells
treated with 5-ALA alone or in combination with the compounds
described on the figure. The cells were treated for 4h in serum-
free medium and porphyrins extracted from the cells as described
in Materials and methods. Standards for uroporphyrin (URO),
coproporphyrin (COPRO) and PpIX are included.
was performed on the cells. Only DEF induced a substantial
inhibition of the colony-forming ability of the cells and only
at concentrations higher than 0.1 mM (data not shown).
EDTA was found to reduce the number of colonies in some
cases. This was assumed to be due to the effect of EDTA on
the binding of cells to the substratum.
The cytotoxic effect of DEF prohibited comparative
studies of the combination of 5-ALA-PCT and optimal
concentrations of iron chelators. Therefore, suboptimal
concentrations (100 uM) of the modulators have been
combined with 5-ALA-PCT in a colony-forming assay. The
sensitivity of the cells to photoinactivation was substantially
enhanced by the iron chelators only at the low concentration
of 5-ALA (Figure 12). Also in accordance with the results on
PpIX accumulation, DEF sensitised the cells to photoinacti-
vation to a higher extent than EDTA. DDC did not
significantly change the sensitivity of the cells to ALA-PCT
despite a reduced formation ofPpIX in the presence of DDC.
Discussion
The purpose of the current studies has been to elucidate
further the influence of iron chelators on the rate of PpIX
accumulation. This has been performed by studying the effect
of the iron chelators, EDTA and DEF, at different
concentrations of chelators and 5-ALA. Both chelators have
previously been applied to cells in vitro and shown to increase
the accumulation of PpIX and the sensitivity of the cells to
photoinactivation in the presence of 5-ALA (Hanania and
Malik, 1992; Ortel et al., 1993). However, a complete study
to reveal the maximal possible gain in using iron chelators at
different concentrations of 5-ALA has not previously been
performed. The two iron chelators compared in this study
have different physicochemical properties. EDTA is a
membrane-impermeable chelator (Richardson et al., 1994)
with affinity for several cations, of which that for Fe3" is
notably high (logK,. %25) compared with that for, for
example, Ca2" (logKm 10.7; Keberle, 1964). EDTA has
been used clinically in a cream together with 5-ALA and
dimethyl sulphoxide (DMSO) for topical application
(Heyerdahl et at., 1993; Orenstein et al., 1994). The
sideramine DEF, on the other hand, is a highly specific
membrane-permeable iron chelator with very high affinity for
iron (logK=31; Keberle, 1964). DEF has so far not been
used in clinical 5-ALA-PCT, but is promising as an anti-ALA-PDT and iron chelators
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Figure 11 Fluorescence micrographs of V79 cells treated with 0.1 mm 5-ALA alone or in combination with iron chelators as
indicated on the figure. The cells were treated for 4h in serum-free medium as described in Materials and methods.
neoplastic agent alone and is currently used clinically to treat
iron overload diseases such as thalassemia and transfusion-
related overload (Blatt, 1994; Richardson et al., 1994). In the
present study both chelators were found to increase the
accumulation of PpIX in 5-ALA-treated cells, although DEF
was more efficient on a molar basis (Figures 3 and 5). This is
most likely because of the intracellular localisation of DEF,
the slow release of iron from cells (Richardson et al., 1994)
and EDTA's binding to other cations. DEF supposedly binds
iron from the intracellular iron pool which most likely
consists of small molecular weight iron chelates of sugars,
amino acids and nucleotides, all with low affinity for iron
(Jacobs, 1977) in addition to ferritin. In this way DEF may
reduce the amount of iron accessible for the ferrochelatase.
On the basis of the present results, it may be advantagous to
use DEF instead of EDTA as enhancer of PpIX accumula-
tion. Our recent results also indicate that the gain in using
DEF is significantly higher than that in using EDTA in
combination with 5-ALA for the formation of fluorescing
porphyrins in mouse skin (Peng et al., 1996).
The iron chelator-induced increase in PpIX accumulation
(AV) was found to be saturable (Figure 7). The linear
relationship between AV`1 and [DEF]-' indicates that the
rate of iron incorporation into PpIX in cells follows
Michaelis-Menten kinetics. This is in accordance with data
on purified ferrochelatase (Taketani and Tokunaga, 1982;
Ferreira, 1994). In both V79 and WiDr cells the accumulation
of PpIX is increased from the medium to the highest
concentrations of 5-ALA (Figure 1), whereas the double-
reciprocal curves for DEF-induced increase in PpIX
accumulation (Figure 8) have the same intercepts with the
ordinate for these concentrations of 5-ALA. This indicates
that saturating concentrations of PpIX are provided to the
ferrochelatase when WiDr and V79 cells are treated with 5-
ALA concentrations above 0.3 mm and 0.05 mm respectively.
Furthermore, assuming the mean diameter of WiDr and V79
cells to be 15 and 11 gum, respectively, the mean maximal
PpIX concentration in both cell lines will be approximately
50-150 gM after 4 h of 5-ALA treatment. This is similar to
the Km,ppix of isolated ferrochelatase (50-100 gM; TaketaniALA-PDT and iron chelators
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WiDr cells
1 mM 5-ALA
V79 cells
0.1 mM 5-ALA
Figure 12 Surviving fraction of WiDr and V79 cells treated with 5-ALA (at concentrations as indicated on the figure) alone (LI )
or in combination with 1OOUM EDTA (M), 100,iM DEF (_) or 100liM DDC (E ). Light doses were adjusted so that 30-50%
of the cells treated with 5-ALA alone were killed. The cells were exposed to the following doses of light: V79 cells, 0.025 mm 5-ALA:
15min; 0.1 mm 5-ALA: 2min. WiDr cells, 0.1 mm 5-ALA: 4min; mm 5-ALA: 0.5min. Survival was measured in triplicate by a
colony-forming assay as described in Materials and methods.
and Tokunaga, 1982; Ferreira, 1994). However, PpIX is
clearly not homogeneously distributed intracellularly but
highly concentrated in mitochondria (linuma et al., 1994),
lysosomes (Gaullier et al., 1995) and the plasma membrane
(Figure 11) (Gaullier et al., 1995), which may also suggest
saturating PpIX concentrations around the mitochondrial
ferrochelatase. Hence, the present results indicate that the
intercept with the ordinate in the double-reciprocal plot can
be used to estimate ferrochelatase activity in cells. However,
it should be emphasised that the values obtained by this
method may differ from the maximum ferrochelatase activity,
since availability to iron may be rate limiting even in the
absence of iron chelators. Furthermore, 5-ALA- and DEF-
induced changes in the intracellular concentrations of
modulators of ferrochelatase activity may influence the
estimated activities. For example, haemin, the oxidised form
of haem, is known to inhibit ferrochelatase activity (Rossi et
al., 1990). It cannot be excluded that DEF may be an inducer
ofother enzymes in the pathway leading to a haem formation
(Sassa and Bernstein, 1977).
There are several examples from the literature suggesting
that the ferrochelatase activity is reduced in neoplastically
transformed tumours compared with their normal counter-
parts (Rebeiz et al., 1992; Dailey and Smith, 1984; van
Hillegersberg et al., 1992). The present results indicate that in
WiDr cells there is a 3-fold higher capacity for formation of
PpIX than the capacity for incorporation of ferrous iron into
PpIX (Figure 9). On the other hand, in V79 cells the same
ratio is only 1.5: 1. This difference between the two cell lines
may be owing to the difference in origin of these cell lines.
V79 cells are derived from normal Chinese hamster lung
fibroblasts, while WiDr cells are derived from a human
adenocarcinoma. Thus, the V79 cells may, to some extent,
resemble non-transformed cells with respect to the biosyn-
thetic properties. It would be of great interest to perform
studies similar to the present ones on normal cells and their
neoplastic counterparts. One may speculate that the
enhancement of PpIX accumulation by the use of iron
chelators in combination with 5-ALA may be more
pronounced in normal cells than in neoplastically trans-
formed cells. Thus, systemic treatment with iron chelators in
combination with 5-ALA may reduce the selectivity of the
treatment. On topical application there may be a therapeutic
gain in the deeper layers of the tumour where less PpIX is
formed, in using a combination of 5-ALA and iron chelators
(Orenstein et al., 1994). As seen in the present study, the
largest benefit of co-treatment with iron chelators is found at
low concentrations of 5-ALA (Figures 3 and 5).
The iron chelator-induced accumulation of PpIX was
dependent upon the cell line and the concentration of 5-ALA
(Figure 9). The highest effect was observed at the lowest
concentration of 5-ALA, and the accumulation could be
increased to a higher extent in V79 cells than in WiDr cells.
At low concentrations of 5-ALA (<0.025 mM) virtually no
PpIX is accumulated in V79 cells. At these low concentra-
tions of 5-ALA ferrochelatase is most likely able to convert
all PpIX formed into haem. This is supported by the nearly
linear relationship between PpIX accumulation and 5-ALA
concentration when the ferrochelatase activity is inhibited by
DEF treatment (Figure 6).
The iron chelators were also found to enhance the
sensitivity of the cells to photoinactivation (Figure 12). The
studies of PpIX accumulation in cells indicated that iron
chelators should be more efficient in increasing the sensitivity
of the cells to photoinactivation at low than at high
concentrations of 5-ALA. Furthermore, DEF should be
expected to be more efficient than EDTA in increasing the
sensitivity of the cells to photoinactivation. This was indeed
found to be the case for both V79 and WiDr cells (Figure
12). The enhancement was found to be strictly dependent on
the amount of PpIX in the cells (data not shown), indicating
that the iron chelators do not change the intracellular
localisation of PpIX or in other ways change the quantum
yield for photoinactivation of the accumulated porphyrins.
The fluorescence micrography studies confirmed that no
major changes in intracellular localisation of PpIX was
induced by the modulators (Figure 11). HPLC analysis
showed that only PpIX was accumulated in the presence or
absence of iron chelators in 5-ALA-treated cells (Figure 10).
DDC is well known to elevate the haem precursor level in
mice and rats (Ortiz de Montellano et al., 1981) by markedly
decreasing the hepatic ferrochelatase (Brady and Lock, 1992;
0.1 mM 5-ALA
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Kimmett et al., 1992). This is not due to a direct effect of
DDC, but rather to the accumulation of N-methyl
protoporhyrin IX in hepatocytes by transfer of methyl
groups from DDC to PpIX (Ortiz de Montellano et al.,
1981). N-methyl protoporphvrin IX is a potent inhibitor of
ferrochelatase (Kimmett et al.. 1992). The present results
indicate that the transfer of the methyl group from DDC to
PpIX does not occur in non-hepatic cells. In contrast. it was
found that the accumulation of PpIX was reduced by DDC
treatment of cells exposed to 5-ALA (Figures 2-5). This
inhibition may be cell line dependent (Schoenfeld et al..
1994). Since no porphyrins other than PpIX were found in 5-
ALA- and DDC-treated cells (Figure 10), DDC is likely to
interact at a step in the haem biosynthetic pathway before the
formation of uroporphyrin or with the uptake of 5-ALA into
the cells.
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